News Contact Us Careers Get E-Mail alerts Search

ADMA Biologics, Inc.

  • Home
  • About Us
    • About ADMA Biologics
    • What We Do
    • Who We Are
      • Senior Leadership Team
      • Board of Directors
      • Scientific Advisory Board
      • Medical Affairs
      • Compliance
  • Our Products
    • Products Overview
    • About Primary Immunodeficiency Disease (PI)
    • ASCENIV™
    • BIVIGAM®
    • Nabi-HB®
  • Our Pipeline
  • Immunotechnology
  • Plasma & IVIG
  • Investors
    • Overview
    • Press Releases
      • Email Alerts
    • Company Info
      • Profile
      • Presentation
      • Management Team
      • Contacts
      • FAQ
    • Analyst Coverage
    • Events & Webcasts
    • Financial Info
      • Balance Sheets
      • Income Statement
      • Cash Flow
      • Financial Results
      • Annual Reports
    • Stock Info
      • Stock Data & Quote
      • Charts
      • Historical Data
    • SEC Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Documents
  • News
  • Contact Us
  • Careers
  • Get E-Mail alerts
  • Search

You are now leaving www.admabiologics.com

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

Yes No

Annual Reports

Investors

Investors

  • Overview
  • Press Releases
    • Email Alerts
  • Company Info
    • Profile
    • Presentation
    • Management Team
    • Contacts
    • FAQ
  • Analyst Coverage
  • Events & Webcasts
  • Financial Info
    • Balance Sheets
    • Income Statement
    • Cash Flow
    • Financial Results
    • Annual Reports
  • Stock Info
    • Stock Data & Quote
    • Charts
    • Historical Data
  • SEC Filings
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Documents
  • home Home
  • Investors
  • Financial Information
  • Annual Reports
  • Financial Info

  • Balance Sheets
  • Income Statement
  • Cash Flow
  • Financial Results
  • Annual Reports

FY 2019

Fiscal Year Ended Dec 31, 2019
Year End Results
Earnings Release
PDF HTML
Audio
Earnings Webcast
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML
Annual Report
PDF

FY 2018

Fiscal Year Ended Dec 31, 2018
Year End Results
Earnings Release
PDF HTML
Report Title
HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML
Annual Report
PDF

FY 2017

Fiscal Year Ended Dec 31, 2017
Year End Results
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML
Annual Report
PDF

FY 2016

Fiscal Year Ended Dec 31, 2016
Year End Results
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML
Annual Report
PDF

FY 2015

Fiscal Year Ended Dec 31, 2015
Year End Results
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML
Annual Report
PDF

FY 2014

Fiscal Year Ended Dec 31, 2014
Year End Results
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML
Annual Report
PDF

FY 2013

Fiscal Year Ended Dec 31, 2013
Year End Results
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML
Annual Report
PDF
About Us Our Products Our Pipeline Inmunotechnology Plasma & IVIG Investors Privacy Policy Disclaimer Sitemap Contact Us Connect with Us Email Alerts RSS

© Copyright 2021 ADMA Biologics, Inc.
Ramsey, NJ Offices 201-478-5552
Boca Raton, FL Offices 561-989-5800
info@admabio.com

Best places to work
Bio NJ

2020 Innovator Award

50 fastest companies
2019 Fast 500 Deloitte
Bio Florida

Named 2019 Company of the Year